Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | September 2019

After the Meta-Analysis…

By Sabine Steiner, MD, and Ramon L. Varcoe, MBBS, MS, FRACS, PhD

evt | Article | September 2021

Panel Discussion: Endovascular Therapies for TASC C and D Femoropopliteal Disease

Prof. Ramon L. Varcoe asks Drs. Herbert D. Aronow, Darren B. Schneider, and Sabine Steiner about current evidence for treatment of TASC C and D lesions, their preferred access and approach to advanced disease, if lesion location affects decision-making, and which new therapies hold promise for treating these complex lesions.

evt | Article | February 2014

Ask the Experts

What are your primary solutions for stent graft migration? Have you seen upward migration in the iliacs? How do you manage this?

With Edward Woo, MD; Ross Milner, MD; Ramon L. Varcoe, MD, FRACS; Dittmar Böckler, MD; Ramesh K. Tripathi, MD, FRCS, FRACS; and William D. Jordan, Jr, MD

evt | Article | February 2014

Ask the Experts

What are your primary solutions for stent graft migration? Have you seen upward migration in the iliacs? How do you manage this?

With Edward Woo, MD; Ross Milner, MD; Ramon L. Varcoe, MD, FRACS; Dittmar Böckler, MD; Ramesh K. Tripathi, MD, FRCS, FRACS; and William D. Jordan, Jr, MD

Advertisement

Advertisement

evt | Article | February 2014

Ask the Experts

What are your primary solutions for stent graft migration? Have you seen upward migration in the iliacs? How do you manage this?

With Edward Woo, MD; Ross Milner, MD; Ramon L. Varcoe, MD, FRACS; Dittmar Böckler, MD; Ramesh K. Tripathi, MD, FRCS, FRACS; and William D. Jordan, Jr, MD

evt | Article | September 2019

Panel Discussion: Exploring the Paclitaxel Safety Signal

Experts discuss considerations in trial design, adjudication, and paths forward.

With Marianne Brodmann, MD; William Gray, MD; Peter A. Schneider, MD; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; and Thomas Zeller, MD, PhD

evt | Article | May 2021

The State of Stenting in Below-the-Knee Applications

Assessing stent options and additional technologies for below-the-knee interventions.

By Nedal Katib, MBBCh BAO, MS, FRACS, and Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi)

evt | Article | September 2022

Roundtable Discussion: The Future of the Vascular Meeting

Leading physicians who play an active role in the development of meetings in the vascular space offer insight into the evolving landscape of conferences.

Moderator: Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed(ClinEpi);
Panelists: Venita Chandra, MD; Afshin Gangi, MD, PhD; Tara M. Mastracci, MD, FRCSC; and Parag J. Patel, MD, MS, FSIR

evt | Article | October 2016

Ask the Experts: What Will Dominate the Next Era in SFA Therapy?

Experts discuss the current era of drug-eluting technologies and what might come next.

With Koen Deloose, MD; Craig Walker, MD; and Ramon L. Varcoe, MBBS, MS, FRACS, PhD

evt | Article | September 2025

Are DRS Ready for Prime Time in the Infrapopliteal Circulation?

A review of current-generation below-the-knee drug-eluting resorbable scaffolds, focusing on their appropriate use and where they are headed next.

By Abigail L. Kleine and Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed(ClinEpi)

evt | Article | May 2015

Hybrid Surgery Techniques for the Treatment of Critical Limb Ischemia

An overview of combined open surgical and endovascular approaches to managing limb-threatening multilevel disease.

By Shannon D. Thomas, BMedSc Hons, MBBS (Hons), FRACS; Andrew F. Lennox, MBBS, MSc, FRACS; and Ramon L. Varcoe, MBBS, MS, FRACS

evt | Article | September 2017

Ask the Experts: Perfect Pairing: Which Stent Properties Are the Best Match for Drug-Coated Balloons?

Experts weigh in on properties of available stent technology and which combinations could be used to improve femoropopliteal disease outcomes.

With Stavros Spiliopoulos, MD, PhD, EBIR; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; Mark W. Burket, MD; and Thomas Zeller, MD

evt | Article | May 2018

Considerations for the Near Future of Drug Delivery Devices Below the Knee

A global panel of limb salvage experts weighs in on the promise and pitfalls facing adoption of drug-based options.

With Marianne Brodmann, MD; Antonio Micari, MD, PhD; Jihad A. Mustapha, MD, FACC, FSCAI; and Ramon L. Varcoe, MBBS, MS, FRACS, PhD

evt | Article | May 2019

Ask the Experts: What Is Your Top Tip on How to Safely and Efficiently Cross a Lower Extremity CTO?

Experts discuss their access approaches to and techniques for crossing chronic total occlusions.

With John A. Phillips, MD; Saher Sabri, MD, FSIR; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; Sabine Steiner, MD; and Osamu Iida, MD

evt | Article | May 2017

Ask the Experts: How Can Current Endpoints in Below-the-Knee Clinical Trials Be Improved?

Experts discuss how to better align trial endpoints for improved assessment of below-the-knee outcomes in patients with critical limb ischemia.

With Thomas Zeller, MD; Mahmood K. Razavi, MD, FSIR, FSVM; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; and Marianne Brodmann, MD

evt | Article | September 2024

Drug Delivery From ATK to BTK: What Is on the Horizon?

Experts discuss differences in drug delivery between ATK and BTK, the future of sirolimus-coated balloons, device innovation in the infrapopliteal arteries, where drug-eluting bioresorbable scaffolds fit into the BTK algorithm, and the most significant unmet needs.

With moderator Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed(ClinEpi), and panelists Marianne Brodmann, MD; Osamu Iida, MD, PhD; Sahil A. Parikh, MD; and Peter A. Schneider, MD

evt | Article | September 2020

Roundtable Discussion: Paclitaxel in PAD: Where We Stand

A panel discussion on the current state of paclitaxel in peripheral artery disease, including how device use has changed, conversations with patients about safety and informed consent, key lessons learned, and how to move forward.

With Daniel J. Bertges, MD; Theodosios Bisdas, MD; Bruce H. Gray, DO, FSCAI, MSVM; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; and Sabine Steiner, MD; with additional commentary by Jos C. van den Berg, MD, PhD

evt | Article | March 2022

Utility of Registry Analysis of Long-Term EVAR Trends

Moderator Jack Cronenwett, MD, asks a group of expert panelists about improving EVAR follow-up across patient populations, advantages and limitations of registry data to evaluate devices, efforts to link data across registries, and how to support future study efforts.

With Benjamin Brooke, MD, PhD, FACS, DFSVS; Philip P. Goodney, MD, MS; Kevin Mani, MD, PhD, FEBVS; Marc Schermerhorn, MD; Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi); and Grace J. Wang, MD, MSCE

evt | News | November 5, 2019

Five-Year Results From ABSORB BTK Trial Presented

November 6, 2019—The 5-year results of the ABSORB BTK trial—a prospective, nonrandomized, single-center study evaluating a novel bioresorbable, drug-eluting scaffold for the treatment of peripheral artery disease below the knee—were presented by Ramon L. Varcoe, MBBS, MS, PhD, during a late-breaking clinical trial session at VIVA 2019, the Vascular InterVentional Advances meeting held November 4–7 in Las Vegas, Nevada. Prof. Varcoe is Associate Professor of Vascular Surgery at the University of New South Wales in Sydney, Australia.

evt | News | August 30, 2016

Abbott Vascular's Absorb Bioresorbable Vascular Scaffold Studied for BTK Treatment

August 30, 2016—In 12-month clinical and imaging follow-up, the Absorb everolimus-eluting bioresorbable vascular scaffold (Abbott Vascular) demonstrated excellent safety, patency, and freedom from target lesion revascularization for the treatment of below-the-knee (BTK) arteries, concluded Ramon L. Varcoe, MBBS, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2016;9:1721–1728). 


1
2

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button